FindTrial
Sign In

THE EFFECT OF ATIVISHADI SYRUP AND PATHYADI SYRUP IN KASA W.S.R. TO UPPER RESPIRATORY TRACT INFECTION IN CHILDREN

A COMPARATIVE CLINICAL STUDY ON THE EFFECT OF ATIVISHADI SYRUP AND PATHYADI SYRUP IN KASA W.S.R. TO UPPER RESPIRATORY TRACT INFECTION IN CHILDREN.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/014867
Enrollment
60
Registered
2018-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PATIENT DIAGNOSED WITH KASA UPPER RESPIRATORY TRACT INFECTION

Interventions

Intervention1: ATIVISHADI CHURNA: ATIVISHADI CHURNA HAS BEEN MENTIONED BY ASTANG HRIDYAM CONTAIN ATIVISHA, PIPPLI, KAKARASHRINGI ROUTE OF ADMISTRATION - ORAL ANUPAN- WATER FORMULATION OF DRUG- SYRUP

Sponsors

CAMPUS DIRECTOR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: AGE BETWEEN 1 TO 12 YEAR PATIANT PRESENTING WITH CLASSICAL SYMPTOMS OF KASA AS PER THEIR DOSHAS VATAJA KASA, PITTAJA KASA,KAPHAJA KASA PATIENT NOT RECEIVED ANY ANTIBIOTIC TREATMENT IN LAST TWO DAYS.

Exclusion criteria

Exclusion criteria: AGE UNDER 1 YEAR AND ABOVE 12 YEARS PATIENT PRESENT WITH PENUMONIA,TB,EMPHYSEMA, DIPHTHERIA,CONGENITAL ANOMALIES,KSHYAJA KASA,KSHTAJA KASA

Design outcomes

Primary

MeasureTime frame
change in score of clinical parameters of vataja,pittaj and kaphaja kasaTimepoint: at registration,at 7th day and 15 day—

Secondary

MeasureTime frame
HEMOGLOBIN, TLC, DLC, ESR, XRAY CHESTTimepoint: AT REGISTRATION, AT 15TH DAY—

Countries

India

Contacts

Public ContactYASHPAL SINGH

UTTARAKHAND AYURVEDA UNIVERSITY HARIDWAR

drgarggp@gmail.com9411178353

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026